South Africa H1N1 Vaccines Market Report 2022 to 2030

South Africa H1N1 Vaccines Market Analysis

$ 3999

South Africa H1N1 Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the H1N1 vaccines market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.

ID: IN10ZAPH291 CATEGORY: Pharmaceuticals GEOGRAPHY: South Africa AUTHOR: Riddhi Solanki

Buy Now

South Africa H1N1 Vaccines Market Analysis Summary

South Africa H1N1 Vaccines Market is valued at around $43.8 Mn in 2022 and is projected to reach $76.4 Mn by 2030, exhibiting a CAGR of 7.2% during the forecast period 2023-2030.

Influenza activity increased globally, and especially influenza A(H3N2) virus subtype became predominant. Of 229,940 specimens tested, 15,723 were positive for influenza viruses. The share of influenza A and influenza B viruses was 14,589 (92.8%) and 1134 (7.2%). While all characterized B viruses belonged to the B/Victoria lineage, 1424 (21.2%) and 5284 (78.8%) of 14,589 influenza A viruses were H1N1 and H3N2, respectively. Key drivers of the H1N1 vaccine market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in the H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.

Market Dynamics

Market Growth Drivers

Prevalence: Global H1N1 influenza outbreaks and pandemics, such as the 2009 swine flu pandemic, stimulate demand for H1N1 vaccines as a preventive strategy
Government initiatives and vaccination programs: Government attempts to manage and prevent H1N1 outbreaks via vaccination campaigns and immunization programs help to drive market growth
Increasing knowledge and healthcare spending: Growing public awareness of the necessity of influenza vaccinations, as well as increased healthcare spending, drive up demand for H1N1 vaccines
Vaccine development and production developments: Technological advancements and innovations in vaccine development and production processes result in better vaccines, fueling market growth

Market Restraints

Vaccine production challenges: During peak demand periods, the complex production process and limited production capacities of H1N1 vaccines might create supply constraints and impede the market growth
Concerns about vaccine safety: Concerns about safety and vaccine reluctance among some people may affect the adoption and uptake of H1N1 vaccines
Regulatory stumbling blocks: Stringent regulatory standards and licensing processes for vaccines can be time-consuming and expensive, making market entry difficult
Seasonality of demand: Demand for H1N1 vaccines is often seasonal, with peaks during influenza seasons, resulting in market volatility

Competitive Landscape

Key Player

Sanofi Pasteur
GlaxoSmithKline plc
Seqirus (a subsidiary of CSL Limited)
AstraZeneca plc
Sinovac Biotech Ltd.
Hualan Biological Engineering Inc.
Changchun BCHT Biotechnology Co.
Serum Institute of India Pvt. Ltd.
Daiichi Sankyo Company
Novartis AG.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

South Africa H1N1 Vaccines Market Segmentation

By Vaccine Type

Inactivated (killed) Vaccines
Live attenuated Vaccines

By Distribution Channel

Hospitals
Clinics
Retail Pharmacies
Government Vaccination Programs

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.